259 related articles for article (PubMed ID: 30767226)
21. The effect of an iron chelating agent on protoporphyrin IX levels and phototoxicity in topical 5-aminolaevulinic acid photodynamic therapy.
Choudry K; Brooke RC; Farrar W; Rhodes LE
Br J Dermatol; 2003 Jul; 149(1):124-30. PubMed ID: 12890205
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms involved in delta-aminolevulinic acid (ALA)-induced photosensitivity of tumor cells: relation of ferrochelatase and uptake of ALA to the accumulation of protoporphyrin.
Ohgari Y; Nakayasu Y; Kitajima S; Sawamoto M; Mori H; Shimokawa O; Matsui H; Taketani S
Biochem Pharmacol; 2005 Dec; 71(1-2):42-9. PubMed ID: 16288996
[TBL] [Abstract][Full Text] [Related]
23. A comparative study on the enhancement efficacy of specific and non-specific iron chelators for protoporphyrin IX production and photosensitization in HaCat cells.
Xia Y; Huang Y; Lin L; Liu X; Jiang S; Xiong L
J Huazhong Univ Sci Technolog Med Sci; 2009 Dec; 29(6):765-70. PubMed ID: 20037824
[TBL] [Abstract][Full Text] [Related]
24. Silencing of human ferrochelatase causes abundant protoporphyrin-IX accumulation in colon cancer.
Kemmner W; Wan K; Rüttinger S; Ebert B; Macdonald R; Klamm U; Moesta KT
FASEB J; 2008 Feb; 22(2):500-9. PubMed ID: 17875605
[TBL] [Abstract][Full Text] [Related]
25. Kinetic Evaluation of Determinant Factors for Cellular Accumulation of Protoporphyrin IX Induced by External 5-Aminolevulinic Acid for Photodynamic Cancer Therapy.
Nakanishi T; Ogawa T; Yanagihara C; Tamai I
J Pharm Sci; 2015 Sep; 104(9):3092-100. PubMed ID: 25959076
[TBL] [Abstract][Full Text] [Related]
26. Photodynamic therapy involves an antiangiogenic mechanism and is enhanced by ferrochelatase inhibitor in urothelial carcinoma.
Inoue K; Fukuhara H; Kurabayashi A; Furihata M; Tsuda M; Nagakawa K; Fujita H; Utsumi K; Shuin T
Cancer Sci; 2013 Jun; 104(6):765-72. PubMed ID: 23480042
[TBL] [Abstract][Full Text] [Related]
27. Desferrioxamine Enhances 5-Aminolaevulinic Acid- Induced Protoporphyrin IX Accumulation and Therapeutic Efficacy for Hypertrophic Scar.
Chen Y; Deng H; Yang L; Guo L; Feng M
J Pharm Sci; 2023 Jun; 112(6):1635-1643. PubMed ID: 36682488
[TBL] [Abstract][Full Text] [Related]
28. Improving in vitro photodynamic therapy through the development of a novel iron chelating aminolaevulinic acid prodrug.
Curnow A; Perry A; Wood M
Photodiagnosis Photodyn Ther; 2019 Mar; 25():157-165. PubMed ID: 30553949
[TBL] [Abstract][Full Text] [Related]
29. Mechanism of cell death by 5-aminolevulinic acid-based photodynamic action and its enhancement by ferrochelatase inhibitors in human histiocytic lymphoma cell line U937.
Amo T; Kawanishi N; Uchida M; Fujita H; Oyanagi E; Utsumi T; Ogino T; Inoue K; Shuin T; Utsumi K; Sasaki J
Cell Biochem Funct; 2009 Dec; 27(8):503-15. PubMed ID: 19735078
[TBL] [Abstract][Full Text] [Related]
30. Targeting ABCG2 transporter to enhance 5-aminolevulinic acid for tumor visualization and photodynamic therapy.
Chandratre S; Olsen J; Howley R; Chen B
Biochem Pharmacol; 2023 Nov; 217():115851. PubMed ID: 37858868
[TBL] [Abstract][Full Text] [Related]
31. Her2 oncogene transformation enhances 5-aminolevulinic acid-mediated protoporphyrin IX production and photodynamic therapy response.
Yang X; Palasuberniam P; Myers KA; Wang C; Chen B
Oncotarget; 2016 Sep; 7(36):57798-57810. PubMed ID: 27527860
[TBL] [Abstract][Full Text] [Related]
32. Predictive biomarkers for 5-ALA-PDT can lead to personalized treatments and overcome tumor-specific resistances.
Mastrangelopoulou M; Grigalavicius M; Raabe TH; Skarpen E; Juzenas P; Peng Q; Berg K; Theodossiou TA
Cancer Rep (Hoboken); 2022 Dec; 5(12):e1278. PubMed ID: 32737955
[TBL] [Abstract][Full Text] [Related]
33. Comparative Study of the Effects of Ferrochelatase-siRNA Transfection Mediated by Ultrasound Microbubbles and Polyethyleneimine in Combination with Low-dose ALA to Enhance PpIX Accumulation in Human Endometrial Cancer Xenograft Nude Mice Models.
Zhang X; Chen L; Gao L; Gao X; Li N; Song Y; Huang X; Lin S; Wang X
Photochem Photobiol; 2019 Jul; 95(4):1045-1051. PubMed ID: 30582757
[TBL] [Abstract][Full Text] [Related]
34. Enhancement of 5-aminolevulinic acid-based fluorescence detection of side population-defined glioma stem cells by iron chelation.
Wang W; Tabu K; Hagiya Y; Sugiyama Y; Kokubu Y; Murota Y; Ogura SI; Taga T
Sci Rep; 2017 Feb; 7():42070. PubMed ID: 28169355
[TBL] [Abstract][Full Text] [Related]
35. Polymeric iron chelators for enhancing 5-aminolevulinic acid-induced photodynamic therapy.
Nomoto T; Komoto K; Nagano T; Ishii T; Guo H; Honda Y; Ogura SI; Ishizuka M; Nishiyama N
Cancer Sci; 2023 Mar; 114(3):1086-1094. PubMed ID: 36341512
[TBL] [Abstract][Full Text] [Related]
36. Protoporphyrin IX tracer fluorescence modulation for improved brain tumor cell lines visualization.
Piffaretti D; Burgio F; Thelen M; Kaelin-Lang A; Paganetti P; Reinert M; D'Angelo ML
J Photochem Photobiol B; 2019 Dec; 201():111640. PubMed ID: 31734545
[TBL] [Abstract][Full Text] [Related]
37. Aminolevulinic Acid-Based Tumor Detection and Therapy: Molecular Mechanisms and Strategies for Enhancement.
Yang X; Palasuberniam P; Kraus D; Chen B
Int J Mol Sci; 2015 Oct; 16(10):25865-80. PubMed ID: 26516850
[TBL] [Abstract][Full Text] [Related]
38. 5-aminolevulinic acid-mediated photodynamic therapy on Hep-2 and MCF-7c3 cells.
Alvarez MG; Lacelli MS; Rivarola V; Batlle A; Fukuda H
J Environ Pathol Toxicol Oncol; 2007; 26(2):75-82. PubMed ID: 17725533
[TBL] [Abstract][Full Text] [Related]
39. Accumulation of protoporphyrin-IX (PpIX) in leukemic cell lines following induction by 5-aminolevulinic acid (ALA).
Bartosová J; Hrkal Z
Comp Biochem Physiol C Toxicol Pharmacol; 2000 Jul; 126(3):245-52. PubMed ID: 11048674
[TBL] [Abstract][Full Text] [Related]
40. 5-Aminolevulinic Acid-Induced Protoporphyrin IX Fluorescence Imaging for Tumor Detection: Recent Advances and Challenges.
Harada Y; Murayama Y; Takamatsu T; Otsuji E; Tanaka H
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
